Goodwin Procter advised Sectoral Asset Management and Andera Partners on the deal. McDermott Will & Emery advised a syndicate of Amolyt Pharma’s historical investors, including LSP,...
Amolyt Pharma’s $80 Million Series B Financing Round
Novo Holdings’ Investment in Availity
Goldman Sachs & Co. LLC acted as exclusive financial advisor, and Davis Polk & Wardwell LLP and Taft Stettinius & Hollister LLP acted as legal advisors...
Quanta Dialysis Technologies’ $245 Million Series D Funding Round
Goodwin Procter LLP advised Quanta Dialysis Technologies on the deal, while Latham & Watkins advised Novo Holdings. Quanta Dialysis Technologies announced its completion of a $245 million...
Esco Lifesciences’ US$200 Million Series A Financing
Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo...